AllianceBernstein’s Passage Bio PASG Stock Holding History

AllianceBernstein’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-785	Closed	-$49K	–	3346
2022 Q1	$49K	Hold	785	–	–	﹤0.01%	3175
2021 Q4	$100K	Buy	785 +10	+1%	+$1.63K	﹤0.01%	3197
2021 Q3	$154K	Sell	775 -130	-14%	-$31K	﹤0.01%	3136
2021 Q2	$240K	Buy	905 +320	+55%	+$99K	﹤0.01%	3099
2021 Q1	$205K	Sell	585 -380	-39%	-$162K	﹤0.01%	3057
2020 Q4	$494K	Sell	965 -10	-1%	-$4K	﹤0.01%	2595
2020 Q3	$256K	Buy	975 +270	+38%	+$92.9K	﹤0.01%	2875
2020 Q2	$385K	Buy	+705	New	+$317K	﹤0.01%	2767

Other funds holding PASG

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HCM

Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllianceBernstein's PASG Position: Q2 2022 in Review

AllianceBernstein sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 785 shares — an estimated $49K sold.

AllianceBernstein first reported a position in PASG in Q2 2020 and held it in 8 quarters. The position peaked at $494K in Q4 2020. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

AllianceBernstein reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
AllianceBernstein sold 785 Passage Bio shares in Q2 2022, an estimated $49K.
AllianceBernstein first reported a position in Passage Bio in Q2 2020 and held it in 8 quarters.
AllianceBernstein's Passage Bio position peaked at $494K in Q4 2020.
85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.